PL2651965T3 - Cząsteczki analogów cyklosporyny modyfikowane w aminokwasach 1 i 3 - Google Patents
Cząsteczki analogów cyklosporyny modyfikowane w aminokwasach 1 i 3Info
- Publication number
- PL2651965T3 PL2651965T3 PL11848865T PL11848865T PL2651965T3 PL 2651965 T3 PL2651965 T3 PL 2651965T3 PL 11848865 T PL11848865 T PL 11848865T PL 11848865 T PL11848865 T PL 11848865T PL 2651965 T3 PL2651965 T3 PL 2651965T3
- Authority
- PL
- Poland
- Prior art keywords
- amino acid
- molecules modified
- analogue molecules
- cyclosporine analogue
- cyclosporine
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical class CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42357610P | 2010-12-15 | 2010-12-15 | |
| PCT/CA2011/050773 WO2012079172A1 (en) | 2010-12-15 | 2011-12-14 | Cyclosporine analogue molecules modified at amino acid 1 and 3 |
| EP11848865.9A EP2651965B1 (en) | 2010-12-15 | 2011-12-14 | Cyclosporine analogue molecules modified at amino acid 1 and 3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2651965T3 true PL2651965T3 (pl) | 2019-04-30 |
Family
ID=46243924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11848865T PL2651965T3 (pl) | 2010-12-15 | 2011-12-14 | Cząsteczki analogów cyklosporyny modyfikowane w aminokwasach 1 i 3 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US9200038B2 (pl) |
| EP (2) | EP2651965B1 (pl) |
| JP (3) | JP6144627B2 (pl) |
| KR (3) | KR20190002731A (pl) |
| CN (2) | CN107496902B (pl) |
| AU (1) | AU2011342284C1 (pl) |
| BR (1) | BR112013014890B1 (pl) |
| CA (1) | CA2821009C (pl) |
| DK (1) | DK2651965T3 (pl) |
| ES (1) | ES2705750T3 (pl) |
| HR (1) | HRP20190096T1 (pl) |
| HU (1) | HUE042490T2 (pl) |
| IL (1) | IL226792A (pl) |
| LT (1) | LT2651965T (pl) |
| MX (1) | MX353720B (pl) |
| MY (2) | MY192981A (pl) |
| NZ (1) | NZ611620A (pl) |
| PH (1) | PH12013501213A1 (pl) |
| PL (1) | PL2651965T3 (pl) |
| PT (1) | PT2651965T (pl) |
| RU (1) | RU2630690C9 (pl) |
| SG (2) | SG191069A1 (pl) |
| SI (1) | SI2651965T1 (pl) |
| TR (1) | TR201900128T4 (pl) |
| WO (1) | WO2012079172A1 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9890198B2 (en) | 2010-12-03 | 2018-02-13 | S&T Global Inc. | Cyclosporin derivatives and uses thereof |
| CN107496902B (zh) * | 2010-12-15 | 2022-01-18 | 康卓维尔制药公司 | 在氨基酸1和3位修改的环孢菌素类似分子 |
| US9266927B2 (en) | 2012-06-01 | 2016-02-23 | Allergan, Inc. | Cyclosporin A analogs |
| US20160002299A1 (en) * | 2013-03-01 | 2016-01-07 | Ucl Business Plc | Non-immunosuppressive cyclosporin derivatives as antiviral agents |
| MX2016002458A (es) * | 2013-08-26 | 2016-08-08 | Enanta Pharm Inc | Análogos novedosos de ciclosporina para prevenir o tratar la infección por hepatitis c. |
| WO2016112321A1 (en) | 2015-01-08 | 2016-07-14 | Allergan, Inc. | Cyclosporin derivatives wherein the mebmt sidechain has been cyclized |
| EP3458470A4 (en) * | 2016-05-17 | 2020-04-22 | S&T Global Inc. | NEW CYCLOSPOR DERIVATIVES AND USES THEREOF |
| WO2018106931A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
| WO2018106928A1 (en) | 2016-12-08 | 2018-06-14 | Contravir Pharmaceuticals, Inc. | Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3 |
| WO2018112255A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an immunosuppressant |
| WO2018191579A1 (en) | 2017-04-14 | 2018-10-18 | Contravir Pharmaceuticals, Inc. | Combination therapy for treating viral infections |
| EP3612540A1 (en) | 2017-04-20 | 2020-02-26 | Rising Tide Foundation | Triphenylphosphonium-tethered tetracycyclines for use in treating cancer |
| WO2019246312A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| US12252556B2 (en) | 2018-08-22 | 2025-03-18 | Bacainn Biotherapeutics, Ltd. | Cyclosporine compositions and methods of use |
| CA3171882A1 (en) | 2020-02-19 | 2021-08-26 | Hepion Pharmaceuticals, Inc. | Use of cyclosporine analogues for treating fibrosis |
| MX2022010454A (es) * | 2020-02-25 | 2022-09-19 | Hepion Pharmaceuticals Inc | Uso de analogos de ciclosporina para el tratamiento contra el cancer. |
| BR112022018929A2 (pt) | 2020-03-26 | 2022-12-06 | Farsight Medical Tech Shanghai Co Ltd | Inibidores da ciclofilina e seus usos |
| CN115315432A (zh) * | 2020-03-26 | 2022-11-08 | 睿诺医疗科技（上海）有限公司 | 亲环蛋白抑制剂及其用途 |
| JP2023551503A (ja) * | 2020-11-29 | 2023-12-08 | ヘピオン ファーマシューティカルズ インコーポレイテッド | 抗血栓剤としてのシクロスポリン類似体の使用 |
| CN113173974B (zh) | 2021-03-18 | 2024-09-06 | 北京大学深圳研究生院 | 环孢素衍生物的合成方法 |
| CN115677533B (zh) * | 2021-07-30 | 2023-12-05 | 沈阳化工研究院有限公司 | 一种4-庚基苯甲腈的制备方法 |
| IT202300001116A1 (it) * | 2023-01-25 | 2024-07-25 | Indena Spa | Processo per la preparazione di un intermedio utile per la sintesi di voclosporina |
| WO2024245384A1 (en) * | 2023-06-02 | 2024-12-05 | Farsight Medical Technology (Shanghai) Co., Ltd. | Cyclophilin inhibitors and uses thereof |
| WO2024254480A2 (en) * | 2023-06-08 | 2024-12-12 | Hepion Pharmaceuticals, Inc. | Solid state forms of rencofilstat |
Family Cites Families (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH614931A5 (pl) | 1975-11-04 | 1979-12-28 | Sandoz Ag | |
| US4210581A (en) | 1975-11-04 | 1980-07-01 | Sandoz Ltd. | Organic compounds |
| US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| DE2819094A1 (de) | 1977-05-10 | 1978-11-23 | Sandoz Ag | Cyclosporin-derivate, ihre verwendung und herstellung |
| SE448386B (sv) | 1978-10-18 | 1987-02-16 | Sandoz Ag | Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem |
| AU548156B2 (en) | 1980-02-14 | 1985-11-28 | Novartis Ag | Cyclo sporin |
| US4396542A (en) | 1980-02-14 | 1983-08-02 | Sandoz Ltd. | Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4384996A (en) | 1981-01-09 | 1983-05-24 | Sandoz Ltd. | Novel cyclosporins |
| CH667274A5 (de) | 1984-03-23 | 1988-09-30 | Sandoz Ag | Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
| JPS6182786A (ja) | 1984-09-28 | 1986-04-26 | ブラザー工業株式会社 | ミシン |
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| US4764503A (en) | 1986-11-19 | 1988-08-16 | Sandoz Ltd. | Novel cyclosporins |
| US4885276A (en) | 1987-06-03 | 1989-12-05 | Merck & Co., Inc. | Cyclosporin analogs with modified "C-9 amino acids" |
| US4798823A (en) | 1987-06-03 | 1989-01-17 | Merck & Co., Inc. | New cyclosporin analogs with modified "C-9 amino acids" |
| DE3884470T2 (de) | 1987-06-17 | 1994-03-10 | Sandoz Ag | Cyclosporine und deren Benutzung als Arzneimittel. |
| ATE110784T1 (de) | 1987-06-19 | 1994-09-15 | Sandoz Ag | Zyklische peptolide. |
| DE3888357T2 (de) | 1987-06-22 | 1994-09-15 | Merck & Co Inc | Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen. |
| GB8717300D0 (en) | 1987-07-22 | 1987-08-26 | Nat Res Dev | Cyclosporins |
| US5227467A (en) | 1987-08-03 | 1993-07-13 | Merck & Co., Inc. | Immunosuppressive fluorinated cyclosporin analogs |
| US5236899A (en) | 1987-11-16 | 1993-08-17 | Merck & Co., Inc. | 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance |
| US4914188A (en) | 1987-11-16 | 1990-04-03 | Merck & Co., Inc. | Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin |
| US5604092A (en) | 1988-12-05 | 1997-02-18 | The Trustees Of Columbia University In The City Of New York | Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein |
| WO1990006763A1 (en) | 1988-12-05 | 1990-06-28 | The Trustees Of Columbia University In The City Of New York | Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof |
| US5284826A (en) | 1989-07-24 | 1994-02-08 | Sandoz Ltd. | 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins |
| US5214130A (en) | 1990-02-27 | 1993-05-25 | Merck & Co., Inc. | Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| US5122511A (en) | 1990-02-27 | 1992-06-16 | Merck & Co., Inc. | Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| ATE148469T1 (de) | 1990-11-02 | 1997-02-15 | Sandoz Ag | Zyklosporine |
| GB9204466D0 (en) | 1992-03-02 | 1992-04-15 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5948693A (en) | 1994-09-01 | 1999-09-07 | Wisconsin Alumni Research Foundation | Solid phase synthesis of immunosuppressive agents |
| US5639852A (en) | 1994-09-01 | 1997-06-17 | Wisconsin Alumni Research Foundation | Immunostimulatory agents |
| JPH08148407A (ja) | 1994-11-21 | 1996-06-07 | Nikon Corp | 照明光学装置 |
| SE520730C2 (sv) | 1995-01-20 | 2003-08-19 | Eskil Elmer | Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel |
| MY114711A (en) | 1995-06-06 | 2002-12-31 | Pfizer | Substituted n-(indole-2-carbonyl)-b-alanmamides and derivatives as antidiabetic agents |
| ATE209216T1 (de) | 1995-07-17 | 2001-12-15 | Chem Ag C | Cyclosporin-derivate mit anti-hiv-wirkung |
| EP0852233A4 (en) | 1995-09-21 | 1999-09-15 | Nippon Shinyaku Co Ltd | CYCLOSPORIN PHOSPHATE DERIVATIVES AND MEDICINAL COMPOSITION |
| JP3089350B2 (ja) | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
| FR2757521B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2757520B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent |
| FR2757522B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2762843B1 (fr) | 1997-04-30 | 1999-12-10 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US6270957B1 (en) | 1997-08-26 | 2001-08-07 | Wisconsin Alumni Research Foundation | Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection |
| AU8918998A (en) | 1997-08-26 | 1999-03-16 | Wisconsin Alumni Research Foundation | Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection |
| US20030220234A1 (en) | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
| JP4261049B2 (ja) | 1997-10-08 | 2009-04-30 | アイソテクニカ インコーポレイテッド | 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用 |
| US5990274A (en) | 1997-11-25 | 1999-11-23 | Dade Behring Inc. | Cyclosporine derivatives and uses thereof |
| FR2772768B1 (fr) | 1997-12-19 | 2000-01-14 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
| BR9911160A (pt) | 1998-06-12 | 2001-04-03 | Chem Ag C | Ciclosporinas |
| FR2780061B1 (fr) | 1998-06-22 | 2001-09-07 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
| ES2255275T3 (es) | 1998-07-01 | 2006-06-16 | Debiopharm S.A. | Nueva ciclosporina con perfil de actividad mejorado. |
| DE60028936T2 (de) | 1999-02-05 | 2007-01-11 | Debiopharm S.A. | Cyclosporin-derivate und verfahren zu deren herstellung |
| CN1391458A (zh) | 1999-11-19 | 2003-01-15 | Lg生活健康株式会社 | 非免疫抑制性环孢菌素衍生物在促进毛发生长中的应用 |
| US6521595B1 (en) | 1999-11-19 | 2003-02-18 | Lg Chemical, Ltd. | Nonimmunosuppressive [γ-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same |
| KR20020039528A (ko) | 2000-11-22 | 2002-05-27 | 조명재 | 사이클로스포린 7- 티오아미드 유도체를 유효성분으로하는 모발성장촉진제 |
| KR100360716B1 (ko) | 2000-11-22 | 2002-11-13 | 주식회사 엘지생활건강 | 사이클로스포린 에이 7- 티오아미드 유도체를유효성분으로 하는 모발성장촉진제 |
| KR100681670B1 (ko) | 2001-02-14 | 2007-02-09 | 주식회사 엘지생활건강 | [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제 |
| US6784156B2 (en) | 2001-03-05 | 2004-08-31 | Enanta Pharmaceuticals, Inc. | Cyclosporins for the treatment of respiratory diseases |
| ES2256450T3 (es) | 2001-04-20 | 2006-07-16 | Debiopharm S.A. | Ciclosporina modificada utilizable como profarmaco y su uso. |
| KR100465012B1 (ko) | 2001-05-11 | 2005-01-13 | 주식회사 엘지생활건강 | 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제 |
| KR100695611B1 (ko) | 2001-05-17 | 2007-03-14 | 주식회사 엘지생활건강 | [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린유도체를 유효성분으로 하는 모발 성장 촉진제 |
| US20030087813A1 (en) | 2001-10-12 | 2003-05-08 | Or Yat Sun | Cyclosporin analogs for the treatment of lung diseases |
| US6809077B2 (en) | 2001-10-12 | 2004-10-26 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogs for the treatment of autoimmune diseases |
| CN100334106C (zh) * | 2001-10-19 | 2007-08-29 | 伊索泰克尼卡股份有限公司 | 环孢菌素类似物的合成 |
| ES2310604T3 (es) | 2001-10-19 | 2009-01-16 | Isotechnika, Inc. | Mezclas de analogos de ciclosporinas y su uso como agentes inmunomoduladores. |
| DE60233150D1 (de) | 2001-10-19 | 2009-09-10 | Isotechnika Inc | Neue cyclosporin-analoge mikroemulsionsvorkonzentrate |
| US6987090B2 (en) | 2002-05-09 | 2006-01-17 | Lg Household & Health Care Ltd. | Use of 3-position cyclosporin derivatives for hair growth |
| KR100641295B1 (ko) * | 2002-11-11 | 2006-10-31 | 김성수 | 사이클로필린의 항산화제로서의 용도 및 사이클로필린의과발현에 의해 세포이식에서 사이클로스포린 ａ에 의해유발되는 세포독성의 방지 |
| US20040110666A1 (en) | 2002-12-04 | 2004-06-10 | Or Yat Sun | Cyclosporins for the treatment of immune disorders |
| US7012065B2 (en) | 2003-02-07 | 2006-03-14 | Enanta Pharmaceuticals, Inc. | Cyclosporins for the treatment of immune disorders |
| CA2518265A1 (en) | 2003-03-17 | 2004-09-30 | Albany Molecular Research, Inc. | Novel cyclosporins |
| ITMI20030627A1 (it) | 2003-03-31 | 2004-10-01 | Polimeri Europa Spa | Polimeri vinilaromatici espandibili e procedimento per la loro preparazione. |
| TW200505946A (en) | 2003-04-08 | 2005-02-16 | Hoffmann La Roche | Process for preparation of cyclosporin a analog |
| NZ542882A (en) * | 2003-04-11 | 2007-10-26 | Glenmark Pharmaceuticals Sa | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| US20040266669A1 (en) | 2003-06-20 | 2004-12-30 | Wu Frank X. H. | Cyclosporin derivatives for the treatment of immune disorders |
| GB0320638D0 (en) | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| DE102004011988A1 (de) | 2004-03-11 | 2005-09-22 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Cyclosporinderivate und diese enthaltende pharmazeutische Zusammensetzungen |
| US20060015374A1 (en) | 2004-07-19 | 2006-01-19 | Yanhong Ochs | Risk management on the application of crop inputs |
| WO2006014872A2 (en) | 2004-07-29 | 2006-02-09 | Amr Technology, Inc. | Novel processes for stereoselective synthesis of trans isatx 247 |
| US7226906B2 (en) | 2004-08-16 | 2007-06-05 | Array Biopharma, Inc. | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| US20060035821A1 (en) | 2004-08-16 | 2006-02-16 | Hunt Kevin W | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| US7511013B2 (en) * | 2004-09-29 | 2009-03-31 | Amr Technology, Inc. | Cyclosporin analogues and their pharmaceutical uses |
| JP2008514701A (ja) | 2004-09-29 | 2008-05-08 | エーエムアール テクノロジー インコーポレイテッド | シクロスポリンアルキン類似体およびそれらの薬学的使用 |
| EP1802650B1 (en) | 2004-10-01 | 2011-10-26 | Scynexis, Inc. | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
| WO2006041631A2 (en) | 2004-10-06 | 2006-04-20 | Amr Technology, Inc. | Novel cyclosporin alkynes and their utility as pharmaceutical agents |
| DE602005010607D1 (de) | 2004-11-22 | 2008-12-04 | Astellas Pharma Inc | Zyklosporinanalog |
| TW200635954A (en) * | 2004-12-17 | 2006-10-16 | Isotechnika Inc | Metabolites of cyclosporin analogs |
| WO2007041631A1 (en) | 2005-09-30 | 2007-04-12 | Scynexis, Inc. | ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION |
| US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
| US20070232532A1 (en) | 2006-03-28 | 2007-10-04 | Amr Technology, Inc. | Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders |
| US7696166B2 (en) * | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| WO2008069917A2 (en) | 2006-11-20 | 2008-06-12 | Scynexis, Inc. | Novel cyclic peptides |
| CA2730108A1 (en) * | 2008-07-10 | 2010-01-14 | Allergan, Inc. | Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| NZ590517A (en) | 2008-07-30 | 2012-12-21 | Isotechnika Pharma Inc | Nonimmunosuppressive cyclosporine analogue molecules |
| EP2391376A4 (en) | 2009-01-30 | 2012-08-01 | Enanta Pharm Inc | ANALOGUES OF CYCLOSPORIN FOR PREVENTING OR TREATING HEPATITIS C INFECTION |
| US20100305047A1 (en) * | 2009-05-27 | 2010-12-02 | Allergan, Inc. | Cyclosporin derivatives for enhancing the growth of hair |
| KR20120125610A (ko) * | 2009-12-30 | 2012-11-16 | 싸이넥시스, 인크. | 시클로스포린 유사체 |
| RU2013119869A (ru) * | 2010-10-12 | 2014-11-20 | Аллерган, Инк. | Аналоги циклоспорина |
| CA2814191A1 (en) * | 2010-10-12 | 2012-04-19 | Allergan, Inc. | Cyclosporin analogs |
| CN107496902B (zh) * | 2010-12-15 | 2022-01-18 | 康卓维尔制药公司 | 在氨基酸1和3位修改的环孢菌素类似分子 |
-
2011
- 2011-12-14 CN CN201710804889.2A patent/CN107496902B/zh active Active
- 2011-12-14 MY MYPI2018000135A patent/MY192981A/en unknown
- 2011-12-14 RU RU2013127162A patent/RU2630690C9/ru active
- 2011-12-14 SG SG2013044276A patent/SG191069A1/en unknown
- 2011-12-14 EP EP11848865.9A patent/EP2651965B1/en active Active
- 2011-12-14 US US13/994,707 patent/US9200038B2/en active Active
- 2011-12-14 WO PCT/CA2011/050773 patent/WO2012079172A1/en not_active Ceased
- 2011-12-14 CA CA2821009A patent/CA2821009C/en active Active
- 2011-12-14 KR KR1020187037529A patent/KR20190002731A/ko not_active Ceased
- 2011-12-14 CN CN201180067449.4A patent/CN103443119B/zh active Active
- 2011-12-14 PT PT11848865T patent/PT2651965T/pt unknown
- 2011-12-14 NZ NZ611620A patent/NZ611620A/en unknown
- 2011-12-14 KR KR1020137016342A patent/KR102011339B1/ko active Active
- 2011-12-14 BR BR112013014890-0A patent/BR112013014890B1/pt active IP Right Grant
- 2011-12-14 DK DK11848865.9T patent/DK2651965T3/en active
- 2011-12-14 MX MX2013006831A patent/MX353720B/es active IP Right Grant
- 2011-12-14 TR TR2019/00128T patent/TR201900128T4/tr unknown
- 2011-12-14 MY MYPI2013002159A patent/MY165152A/en unknown
- 2011-12-14 SI SI201131640T patent/SI2651965T1/sl unknown
- 2011-12-14 PL PL11848865T patent/PL2651965T3/pl unknown
- 2011-12-14 SG SG10201510236XA patent/SG10201510236XA/en unknown
- 2011-12-14 AU AU2011342284A patent/AU2011342284C1/en active Active
- 2011-12-14 EP EP18187927.1A patent/EP3461835A1/en active Pending
- 2011-12-14 ES ES11848865T patent/ES2705750T3/es active Active
- 2011-12-14 PH PH1/2013/501213A patent/PH12013501213A1/en unknown
- 2011-12-14 HR HRP20190096TT patent/HRP20190096T1/hr unknown
- 2011-12-14 KR KR1020207007384A patent/KR102305423B1/ko active Active
- 2011-12-14 JP JP2013543478A patent/JP6144627B2/ja active Active
- 2011-12-14 HU HUE11848865A patent/HUE042490T2/hu unknown
- 2011-12-14 LT LTEP11848865.9T patent/LT2651965T/lt unknown
-
2013
- 2013-06-06 IL IL226792A patent/IL226792A/en active IP Right Grant
-
2015
- 2015-10-30 US US14/928,885 patent/US9714271B2/en active Active
-
2017
- 2017-02-13 JP JP2017024484A patent/JP6831259B2/ja active Active
-
2019
- 2019-02-04 JP JP2019018182A patent/JP2019123712A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201510236XA (en) | Cyclosporine analogue molecules modified at amino acid 1 and 3 | |
| ZA201207331B (en) | Concentrated protein formulations and uses thereof | |
| IL229353B (en) | Dolestatin derivatives related to unnatural amino acids and medicinal preparations that include them | |
| IL222961A0 (en) | Novel dna-dinding proteins and uses thereof | |
| SI2391620T1 (sl) | Z alkilaminom substituiran dicianopiridin in njegova predzdravila estra amino kisline | |
| IL248880A0 (en) | Preparations containing r-g-cysteic acid peptides and their uses | |
| IL230918A0 (en) | Modified proteins and peptides | |
| GB201010557D0 (en) | RNA molecules and uses thereof | |
| EP2408802A4 (en) | CYCLIC AMINO ACID MOLECULES AND THEIR METHODS OF SYNTHESIS | |
| PL2588491T3 (pl) | Nowy peptyd i jego zastosowanie | |
| ZA201003681B (en) | Compositions and methods comprising basic amino acid peptides and proteases | |
| IL188681A0 (en) | Pharmaceutical compositions and methods utilizing a d-amino acid | |
| ZA201106665B (en) | Products comprising n-phenylpropenoyl amino acid amides and uses thereof | |
| EP2593595A4 (en) | NOVEL PEPTIDES AND USES THEREOF | |
| IL232867A0 (en) | Preparations of bacteriophage gene 3 protein and use as amyloid binding agents | |
| PL2627668T3 (pl) | Peptydy i ich zastosowanie | |
| PL2464656T3 (pl) | Nowy peptyd i jego zastosowanie | |
| ZA201305485B (en) | Plant protein hydrolysates | |
| ZA201100019B (en) | Variant hhip1 protein and methods and uses thereof | |
| SG173752A1 (en) | Modifications of cupredoxin derived peptides and methods of use thereof | |
| EP2668958A4 (en) | CASPOFUNGIN ANALOGS AND APPLICATIONS THEREOF | |
| IL219182A0 (en) | 2-amino-3-methyl-hex-5-enoic acid and its use in the production of peptides such as bacitracins | |
| PL392256A1 (pl) | N-(Bisfosfonometylo)lizyny oraz sposób ich wytwarzania | |
| IL218428A0 (en) | Multi-site modified sp1 ploypeptides and uses thereof | |
| GB201121226D0 (en) | Modified proteins and peptides |